文献速递骨显像与常规 SPECT

初次全髋关节置换术后有症状与无症状患者SPECT-CT骨示踪剂摄取模式

Patterns of bone tracer uptake on SPECT-CT in symptomatic and asymptomatic patients with primary total hip arthroplasty.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-09-19

该研究前瞻性收集、回顾性分析58例全髋关节置换(THA,31例有症状、27例无症状),用99mTc-HDP SPECT/CT三维定量骨示踪剂摄取(BTU)并按象限和层面定位,比较两组摄取模式及骨水泥与非骨水泥固定的差异。结果显示较高BTU与症状显著相关,但正常BTU不能排除THA后特定病理;全柄BTU比值3.1可区分两组。

要点

  • 无症状组层面1、2、5的BTU显著高于层面3、4、6;有症状组层面1-5的BTU显著高于层面6(p<0.001)。
  • 两组层面4、层面5及整个柄区的BTU差异有统计学意义(p<0.05)。
  • 全柄BTU比值3.1可区分92.6%的无症状组(BTU<3.1)与54.8%的有症状组(BTU≥3.1)。

核心结论

  • 较高的BTU水平与症状显著相关,但正常的BTU不能排除THA后的特定病理。
  • 研究确定了SPECT/CT的BTU阈值,用于区分THA后有症状与无症状患者。

研究设计与样本

  • 前瞻性收集、回顾性分析58例THA,其中有症状组31例、无症状组27例。
  • 所有有症状患者接受标准化详细病史、临床检查、X线片和99mTc-HDP SPECT/CT。
  • 用先前验证的定制软件对SPECT/CT的BTU进行三维定量,并按象限和层面进行解剖定位。
  • 在组内和组间对象限和层面行t检验,对象限内BTU行Pearson相关分析,并绘制受试者工作特征曲线下面积以寻找可区分两组的BTU值。
  • 组内比较骨水泥与非骨水泥柄对BTU强度的影响。

主要发现

  • 61%的患者明确了疼痛原因,最常见的问题为无菌性松动(n=12)。
  • 无症状组层面1、2、5的BTU相似,且这些层面的BTU显著高于层面3、4、6。
  • 有症状组层面1-5的BTU无显著差异,但显著高于层面6(p<0.001)。
  • 两组中层面1(上方)的BTU均显著高于层面2(无症状组p<0.01,有症状组p<0.05)。
  • 两组间层面4、层面5及整个柄区的BTU差异有统计学意义(p<0.05)。

关键数值与推荐

  • 基于整个柄计算的ROC曲线确定BTU比值3.1,可将92.6%的无症状组患者(BTU<3.1)与54.8%的有症状组患者(BTU≥3.1)区分开。
  • 关于固定技术,仅有症状组层面6的BTU在骨水泥与非骨水泥柄之间差异有统计学意义(p<0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The primary purpose of this study was to compare bone tracer uptake (BTU) on SPECT/CT in symptomatic and asymptomatic total hip arthroplasty (THA) and identify a possible relationship between BTU patterns and patient's symptoms. The secondary purpose was to investigate if the fixation methods (cemented versus uncemented) lead to different BTU patterns. METHODS: A total of 58 THAs, 31 symptomatic (group S) and 27 asymptomatic (group AS), were prospectively collected and retrospectively analyzed. All symptomatic patients underwent standardized detailed history, clinical examination, radiographs and 99mTc-HDP SPECT/CT. BTU in SPECT/CT was quantified in three dimensions and anatomically localized in a scheme of quadrants and levels using a customized previously validated software. T tests were used on both quadrants and levels inside and between groups. A Pearson correlation was performed for BTU within the quadrants. An area under receiver operating characteristic curves was drawn in order to find a BTU value that could differentiate the two groups. Within the groups, patients with cemented and uncemented stems were compared for influences on BTU intensity. RESULTS: The causes of pain were identified in 61% of the patients. The most common problem was aseptic loosening (n = 12). In group AS, levels 1, 2 and 5 had similar BTUs. BTUs in these levels were significantly higher than in level 3, 4 and 6. In group S, no significant differences were seen in terms of BTU in level 1-5. However, BTU here was significantly higher than at level 6 (p < 0.001). In both groups, level 1, the superior, had a significantly higher BTU than level 2 (group AS p < 0.01, group S p < 0.05). Comparing the BTU of the two groups among levels, significant differences were found for level 4, level 5 and the entire stem areas (p < 0.05). The ROC curve calculated on the whole stem allowed identification of a BTU ratio of 3.1 that separated the 92.6% patients of group AS with BTU < 3.1 from the 54.8% of patients of group S with a BTU ≥ 3.1. With regards to the fixation technique, only the BTU at the level 6 in group S presented a significant difference between cemented and uncemented stems (p < 0.05). CONCLUSIONS: Higher BTU levels significantly correlated with symptoms, but a normal BTU could not exclude a specific pathology after THA. A threshold of BTU in SPECT/CT was identified to distinguish between symptomatic and asymptomatic patients after THA.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Schweizer T, Schiapparelli FF, Rotigliano N, et al. Patterns of bone tracer uptake on SPECT-CT in symptomatic and asymptomatic patients with primary total hip arthroplasty. Eur J Nucl Med Mol Imaging. 2017. PMID: 28929195. doi:10.1007/s00259-017-3827-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。